Revenue | ₹1,049.90Cr |
Net Profits | ₹40.78Cr |
Net Profit Margins | 3.88% |
Akums Drugs & Pharmaceuticals Ltd’s revenue fell -0.03% since last year same period to ₹1,049.90Cr in the Q2 2025-2026. On a quarterly growth basis, Akums Drugs & Pharmaceuticals Ltd has generated -0.08% fall in its revenue since last 3-months.
Akums Drugs & Pharmaceuticals Ltd’s net profit fell -37.46% since last year same period to ₹40.78Cr in the Q2 2025-2026. On a quarterly growth basis, Akums Drugs & Pharmaceuticals Ltd has generated -35.76% fall in its net profits since last 3-months.
Akums Drugs & Pharmaceuticals Ltd’s net profit margin fell -37.44% since last year same period to 3.88% in the Q2 2025-2026. On a quarterly growth basis, Akums Drugs & Pharmaceuticals Ltd has generated -35.71% fall in its net profit margins since last 3-months.
The revenue for Akums Drugs & Pharmaceuticals Ltd in the Q2 results 2025 was ₹1,049.90Cr.
The net profit for Akums Drugs & Pharmaceuticals Ltd in the Q2 results 2025 was ₹40.78Cr.
The net profit margin for Akums Drugs & Pharmaceuticals Ltd in the Q2 results 2025 was 3.88%.
The revenue for Akums Drugs & Pharmaceuticals Ltd in the Q2 results 2024 was ₹1,050.26Cr.
The net profit for Akums Drugs & Pharmaceuticals Ltd in the Q2 results 2024 was ₹65.21Cr.
The net profit margin for Akums Drugs & Pharmaceuticals Ltd in the Q2 results 2024 was 6.21%.